Fenofibrate Bioequivalence Study (0767-031)

NCT00928694 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: fenofibrate (U.S. formulation)
DRUG: fenofibrate (UK formulation)

Sponsor

Merck Sharp & Dohme LLC